Literature DB >> 11259831

Caco-2 monolayers in experimental and theoretical predictions of drug transport.

P Artursson1, K Palm, K Luthman.   

Abstract

This review examines the use of Caco-2 monolayers in the prediction of intestinal drug absorption. First, the different routes of drug transport in Caco-2 monolayers are compared with those seen in vivo. Second, the prediction of drug absorption in vivo from transport experiments in cell monolayers is discussed for different classes of drugs. Finally, the use of Caco-2 monolayers as a reference model in physico-chemical and theoretical predictions of drug absorption is discussed. We conclude that Caco-2 monolayers can be used to identify drugs with potential absorption problems, and possibly also to select drugs with optimal passive absorption characteristics from series of pharmacologically active molecules generated in drug discovery programs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259831     DOI: 10.1016/s0169-409x(00)00128-9

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  280 in total

1.  Automated absorption assessment using Caco-2 cells cultured on both sides of polycarbonate membranes.

Authors:  P Garberg; P Eriksson; N Schipper; B Sjöström
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

2.  Prediction of membrane permeability to peptides from calculated dynamic molecular surface properties.

Authors:  P Stenberg; K Luthman; P Artursson
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

3.  Messenger RNA expression of transporter and ion channel genes in undifferentiated and differentiated Caco-2 cells compared to human intestines.

Authors:  Pascale Anderle; Vera Rakhmanova; Katie Woodford; Noa Zerangue; Wolfgang Sadée
Journal:  Pharm Res       Date:  2003-01       Impact factor: 4.200

4.  In vitro permeability of poorly aqueous soluble compounds using different solubilizers in the PAMPA assay with liquid chromatography/mass spectrometry detection.

Authors:  Hanlan Liu; Chantel Sabus; Guy T Carter; Chao Du; Alex Avdeef; Mark Tischler
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

5.  Differential modulation of P-glycoprotein expression and activity by non-nucleoside HIV-1 reverse transcriptase inhibitors in cell culture.

Authors:  Elke Störmer; Lisa L von Moltke; Michael D Perloff; David J Greenblatt
Journal:  Pharm Res       Date:  2002-07       Impact factor: 4.200

6.  Isolation and characterization of Caco-2 subclones expressing high levels of multidrug resistance protein efflux transporter.

Authors:  Kazutoshi Horie; Fuxing Tang; Ronald T Borchardt
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

7.  The inhibitory effects of mitragynine on P-glycoprotein in vitro.

Authors:  Noradliyanti Rusli; Azimah Amanah; Gurjeet Kaur; Mohd Ilham Adenan; Shaida Fariza Sulaiman; Habibah Abdul Wahab; Mei Lan Tan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-01-02       Impact factor: 3.000

Review 8.  Microfabricated mammalian organ systems and their integration into models of whole animals and humans.

Authors:  Jong H Sung; Mandy B Esch; Jean-Matthieu Prot; Christopher J Long; Alec Smith; James J Hickman; Michael L Shuler
Journal:  Lab Chip       Date:  2013-04-07       Impact factor: 6.799

9.  Transport and metabolism of some cationic ubiquinone antioxidants (MitoQn) in Caco-2 cell monolayers.

Authors:  Yan Li; J Paul Fawcett; Hu Zhang; Ian G Tucker
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Oct-Dec       Impact factor: 2.441

10.  An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d-alpha-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine.

Authors:  Brendan M Johnson; William N Charman; Christopher J H Porter
Journal:  AAPS PharmSci       Date:  2002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.